Clinical Trial

The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women

Recruiting
View on ClinicalTrials.gov →
Summary
Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of menopause on cardiovascular disease risk factors such as insulin resistance, hypertension, hyperlipidemia, and carotid atherosclerosis using previously collected data. The investigators will look at underlying causes for cardiovascular diseases worsening in menopausal women with HIV by looking at the role of increased inflammation in the body and whether this is altered by weight. The investigators achieve this by enrolling participants who are willing to undergo a whole body MRI.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-23
Trial Details
NCT Number NCT07284082
Lead Sponsor University of California, San Francisco
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions HIV, Menopause, Cardiovascular (CV) Risk, Carotid Arteriosclerosis, Body Composition
Enrollment 90 participants
Start Date 2026-04-17
Primary Completion 2030-03-01 (estimated)
Study Completion 2030-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-22